Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.507
+0.331 (188.02%)
At close: Nov 22, 2024

Nika Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-1.01-1.24-1.05--
Quick Ratio
0.010.190.050.04-
Current Ratio
0.010.190.050.04-
Return on Assets (ROA)
-921.57%-396.10%-315344.22%-914.93%-
Return on Capital (ROIC)
-921.57%-396.10%---
Buyback Yield / Dilution
-3.03%-21.01%-82.77%--
Total Shareholder Return
-3.03%-21.01%-82.77%--
Source: S&P Capital IQ. Standard template. Financial Sources.